This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

RECTOGESIC-product-image

STEXEROL-D3

colecalciferol

Stexerol-D3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin D deficiency, or as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.1

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

Click here for prescribing information.

If someone is in one of the ‘at risk’ groups or has symptoms suggesting a potential
vitamin D deficiency, the best way to confirm a diagnosis is through direct measurement of plasma 25(OH)D.2

The reference ranges used by the Royal Osteoporosis Society (ROS) are as follows. These ranges also align with thresholds identified by ROS.2

  • plasma 25(OH)D < 25 nmol/L is deficient.
  • plasma 25(OH)D of 25–50 nmol/L may be inadequate in some people.
  • plasma 25(OH)D > 50 nmol/L is sufficient for almost the whole population.

The Royal Osteoporosis Society has developed a quick guide for the treatment and management of patients with suspected vitamin D deficiency.2

Average:

  • References

    1. Stexerol-D3 Tablets SPC.

    2. Royal Osteoporosis Society: Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. Available at: https://strwebprdmedia.blob.core.windows. net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf/ Last accessed: June 2024.

    M-SD3-UK-11-23-0003 June 2024